{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T15:00:57Z","timestamp":1791126057464,"version":"4.1.0"},"reference-count":19,"publisher":"Wiley","issue":"9","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":1484,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,9]]},"DOI":"10.1111\/j.1751-7176.2011.00511.x","type":"journal-article","created":{"date-parts":[[2011,8,9]],"date-time":"2011-08-09T18:04:45Z","timestamp":1312913085000},"page":"644-648","source":"Crossref","is-referenced-by-count":72,"title":["Aldosterone Blockers (Mineralocorticoid Receptor Antagonism) and Potassium-Sparing Diuretics"],"prefix":"10.1111","volume":"13","author":[{"given":"Murray","family":"Epstein","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David A.","family":"Calhoun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2011,8,9]]},"reference":[{"key":"10.1111\/j.1751-7176.2011.00511.x-BIB20|cit1","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1161\/01.HYP.0000203732.03784.3b","article-title":"Editorial: mineralocorticoid receptors and cardiovascular damage: it\u2019s not just aldosterone","volume":"47","author":"Funder","year":"2006","journal-title":"Hypertension"},{"key":"10.1111\/j.1751-7176.2011.00511.x-BIB2|cit2","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1161\/HYPERTENSIONAHA.108.119966","article-title":"Reconsidering the roles of the mineralocorticoid receptor","volume":"53","author":"Funder","year":"2009","journal-title":"Hypertension"},{"key":"10.1111\/j.1751-7176.2011.00511.x-BIB3|cit3","doi-asserted-by":"crossref","first-page":"5264","DOI":"10.1210\/en.137.12.5264","article-title":"Exclusion of corticosterone from epithelial mineralocorticoid receptors is insufficient for selectivity of aldosterone action: in vivo binding studies","volume":"137","author":"Funder","year":"1996","journal-title":"Endocrinology"},{"key":"10.1111\/j.1751-7176.2011.00511.x-BIB4|cit4","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1161\/CIRCULATIONAHA.108.816108","article-title":"Multimarker approach to evaluate correlates of vascular stiffness: the Framingham Heart Study","volume":"119","author":"Lieb","year":"2009","journal-title":"Circulation"},{"key":"10.1111\/j.1751-7176.2011.00511.x-BIB5|cit5","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/s00424-008-0616-0","article-title":"Actions of aldosterone in the cardiovascular system: the good, the bad, and the ugly?","volume":"458","author":"Gekle","year":"2009","journal-title":"Pflugers Arch"},{"key":"10.1111\/j.1751-7176.2011.00511.x-BIB25|cit6","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1097\/00004872-200105000-00001","article-title":"Aldosterone and the hypertensive kidney: its emerging role as a mediator of progressive renal dysfunction: a paradigm shift","volume":"19","author":"Epstein","year":"2001","journal-title":"J Hypertens"},{"key":"10.1111\/j.1751-7176.2011.00511.x-BIB26|cit7","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1161\/01.HYP.0000025146.19104.FE","article-title":"Efficacy of eplerenone added to renin-angiotensin blockade in hypertensive patients","volume":"40","author":"Krum","year":"2002","journal-title":"Hypertension"},{"key":"10.1111\/j.1751-7176.2011.00511.x-BIB8|cit8","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1056\/NEJM199909023411001","article-title":"The effect of spironolactone on morbidity and mortality in patients with severe heart failure","volume":"341","author":"Pitt","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1751-7176.2011.00511.x-BIB9|cit9","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/S0895-7061(02)02957-6","article-title":"Eplerenone, a selective aldosterone blocker, in mild-to-moderate hypertension","volume":"15","author":"Weinberger","year":"2002","journal-title":"Am J Hypertens"},{"key":"10.1111\/j.1751-7176.2011.00511.x-BIB10|cit10","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1016\/j.amjmed.2006.03.038","article-title":"Aldosterone blockade: an emerging strategy for abrogating progressive renal disease","volume":"119","author":"Epstein","year":"2006","journal-title":"Am J Med"},{"key":"10.1111\/j.1751-7176.2011.00511.x-BIB11|cit11","doi-asserted-by":"crossref","first-page":"940","DOI":"10.2215\/CJN.00240106","article-title":"Selective aldosterone blockade with eplerenone reduces albuminuria in patients with type 2 diabetes","volume":"1","author":"Epstein","year":"2006","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1111\/j.1751-7176.2011.00511.x-BIB12|cit12","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1161\/01.CIR.0000091405.00772.6E","article-title":"Effects of eplerenone, enalapril, and eplerenone\/enalapril in patients with essential hypertension and left ventricular hypertrophy. The 4E-left ventricular hypertrophy study","volume":"108","author":"Pitt","year":"2003","journal-title":"Circulation"},{"key":"10.1111\/j.1751-7176.2011.00511.x-BIB32|cit13","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1111\/j.1524-6175.2002.01510.x","article-title":"Eplerenone: a new aldosterone receptor antagonist. Are the FDA\u2019s restrictions appropriate?","volume":"4","author":"Sica","year":"2002","journal-title":"J Clin Hypertens (Greenwich)"},{"key":"10.1111\/j.1751-7176.2011.00511.x-BIB33|cit14","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1291\/hypres.27.303","article-title":"Aldosterone-induced organ damage: plasma aldosterone level and inappropriate salt status","volume":"27","author":"Sato","year":"2004","journal-title":"Hypertens Res"},{"key":"10.1111\/j.1751-7176.2011.00511.x-BIB15|cit15","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.amjhyper.2004.08.026","article-title":"Aldosterone-to-renin ratio, arterial stiffness, and the response to aldosterone antagonism in essential hypertension","volume":"18","author":"Mahmud","year":"2005","journal-title":"Am J Hypertens"},{"key":"10.1111\/j.1751-7176.2011.00511.x-BIB16|cit16","doi-asserted-by":"crossref","first-page":"776","DOI":"10.7326\/0003-4819-150-11-200906020-00005","article-title":"Narrative review: the emerging clinical implications of the role of aldostrone in the metabolic syndrome and resistant hypertension","volume":"150","author":"Sowers","year":"2009","journal-title":"Ann Intern Med"},{"key":"10.1111\/j.1751-7176.2011.00511.x-BIB17|cit17","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.pcad.2006.02.002","article-title":"Use of aldosterone antagonists in resistant hypertension","volume":"48","author":"Calhoun","year":"2006","journal-title":"Prog Cardiovasc Dis"},{"key":"10.1111\/j.1751-7176.2011.00511.x-BIB18|cit18","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/j.jash.2008.05.005","article-title":"Effectiveness of the selective aldosterone antagonist eplerenone in treating resistant hypertension","volume":"2","author":"Calhoun","year":"2008","journal-title":"J Am Soc Hypertens"},{"key":"10.1111\/j.1751-7176.2011.00511.x-BIB19|cit19","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1056\/NEJMoa030207","article-title":"Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction","volume":"348","author":"Pitt","year":"2003","journal-title":"N Engl J Med"}],"container-title":["The Journal of Clinical Hypertension"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1751-7176.2011.00511.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,7,6]],"date-time":"2021-07-06T07:41:48Z","timestamp":1625557308000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1751-7176.2011.00511.x"}},"subtitle":["Aldosterone Blockers and Potassium-Sparing Diuretics"],"short-title":[],"issued":{"date-parts":[[2011,8,9]]},"references-count":19,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2011,9]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1751-7176.2011.00511.x","relation":{},"ISSN":["1524-6175"],"issn-type":[{"value":"1524-6175","type":"print"}],"subject":[],"published":{"date-parts":[[2011,8,9]]}}}